1. Home
  2. Analysis
  3. Apokyn
  4. Temaz

Apokyn and Temaz drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Apokyn (apomorphine hydrochloride) and Temaz (temazepam). Common drug interactions include dysphagia among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Apokyn and Temaz. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Apokyn?

Apokyn has active ingredients of apomorphine hydrochloride. eHealthMe is studying from 5,284 Apokyn users. Check the latest studies of Apokyn.

What is Temaz?

Temaz has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 42,293 Temaz users. Check the latest studies of Temaz.

On Jul, 05, 2026

16 people who take Apokyn and Temaz together, and have interactions are studied.

Apokyn and Temaz drug interactions.

What are the common drug interactions of Apokyn and Temaz, by gender? *:

female:

  1. Dysphagia (a condition in which swallowing is difficult or painful)
  2. Parkinson's disease
  3. Death
  4. Drug ineffective

male:

  1. Drug ineffective
  2. Gait disturbance
  3. Blood pressure increased
  4. Dizziness
  5. Drug dependence
  6. Epistaxis (bleed from the nose)
  7. Freezing phenomenon
  8. Glossodynia (a burning or painful sensation in the tongue)
  9. Hallucination (an experience involving the perception of something not present)
  10. International normalised ratio increased

What are the common drug interactions of Apokyn and Temaz, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Anxiety
  2. Drug dependence
  3. Drug ineffective
  4. Gait disturbance
  5. On and off phenomenon
  6. Paralysis

60+:

  1. Death
  2. Drug ineffective
  3. Asthenia (weakness)
  4. Blood pressure increased
  5. Dizziness
  6. Epistaxis (bleed from the nose)
  7. Glossodynia (a burning or painful sensation in the tongue)
  8. Hallucination (an experience involving the perception of something not present)
  9. International normalised ratio increased
  10. Loss of consciousness

What are the existing conditions these people have? *

  1. Parkinson's Disease: 11 people, 68.75%
  2. Stress And Anxiety: 2 people, 12.50%
  3. High Blood Cholesterol: 2 people, 12.50%
  4. Bowel Movement Irregularity: 2 people, 12.50%
  5. Depression: 2 people, 12.50%
  6. Hallucinations (sensations that appear real but are created by your mind): 2 people, 12.50%
  7. Delusion (a false belief or opinion): 1 person, 6.25%
  8. Drowsiness: 1 person, 6.25%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 6.25%
  10. Indigestion: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Apokyn and Temaz?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Apokyn and Temaz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Apokyn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Temaz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Apokyn and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Temaz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on apomorphine hydrochloride and temazepam (the active ingredients of Apokyn and Temaz, respectively), and Apokyn and Temaz (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.